153 related articles for article (PubMed ID: 23106787)
1. Intraperitoneal delivery of a small interfering RNA targeting NEDD1 prolongs the survival of scirrhous gastric cancer model mice.
Fujita T; Yanagihara K; Takeshita F; Aoyagi K; Nishimura T; Takigahira M; Chiwaki F; Fukagawa T; Katai H; Ochiya T; Sakamoto H; Konno H; Yoshida T; Sasaki H
Cancer Sci; 2013 Feb; 104(2):214-22. PubMed ID: 23106787
[TBL] [Abstract][Full Text] [Related]
2. Long Noncoding RNA HOTAIR Promotes Epithelial-Mesenchymal Transition and Is a Suitable Target to Inhibit Peritoneal Dissemination in Human Scirrhous Gastric Cancers.
Takei Y; Hara T; Suzuki A; Mihara K; Yanagihara K
Pathobiology; 2020; 87(5):277-290. PubMed ID: 32937635
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs Associated with Epithelial-Mesenchymal Transition Can Be Targeted to Inhibit Peritoneal Dissemination of Human Scirrhous Gastric Cancers.
Takei Y; Shen G; Morita-Kondo A; Hara T; Mihara K; Yanagihara K
Pathobiology; 2018; 85(4):232-246. PubMed ID: 29847827
[TBL] [Abstract][Full Text] [Related]
4. The metastasis-associated microRNA miR-516a-3p is a novel therapeutic target for inhibiting peritoneal dissemination of human scirrhous gastric cancer.
Takei Y; Takigahira M; Mihara K; Tarumi Y; Yanagihara K
Cancer Res; 2011 Feb; 71(4):1442-53. PubMed ID: 21169410
[TBL] [Abstract][Full Text] [Related]
5. Peritoneal metastatic model for human scirrhous gastric carcinoma in nude mice.
Yashiro M; Chung YS; Nishimura S; Inoue T; Sowa M
Clin Exp Metastasis; 1996 Jan; 14(1):43-54. PubMed ID: 8521616
[TBL] [Abstract][Full Text] [Related]
6. Intraperitoneal administration of a small interfering RNA targeting nuclear factor-kappa B with paclitaxel successfully prolongs the survival of xenograft model mice with peritoneal metastasis of gastric cancer.
Inoue M; Matsumoto S; Saito H; Tsujitani S; Ikeguchi M
Int J Cancer; 2008 Dec; 123(11):2696-701. PubMed ID: 18798274
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic modulation and repression of miR-200b by cancer-associated fibroblasts contribute to cancer invasion and peritoneal dissemination in gastric cancer.
Kurashige J; Mima K; Sawada G; Takahashi Y; Eguchi H; Sugimachi K; Mori M; Yanagihara K; Yashiro M; Hirakawa K; Baba H; Mimori K
Carcinogenesis; 2015 Jan; 36(1):133-41. PubMed ID: 25411357
[TBL] [Abstract][Full Text] [Related]
8. Intraperitoneal administration of an adenovirus vector carrying REIC/Dkk-3 suppresses peritoneal dissemination of scirrhous gastric carcinoma.
Than SS; Kataoka K; Sakaguchi M; Murata H; Abarzua F; Taketa C; Du G; Yashiro M; Yanagihara K; Nasu Y; Kumon H; Huh NH
Oncol Rep; 2011 Apr; 25(4):989-95. PubMed ID: 21249317
[TBL] [Abstract][Full Text] [Related]
9. Development and biological analysis of peritoneal metastasis mouse models for human scirrhous stomach cancer.
Yanagihara K; Takigahira M; Tanaka H; Komatsu T; Fukumoto H; Koizumi F; Nishio K; Ochiya T; Ino Y; Hirohashi S
Cancer Sci; 2005 Jun; 96(6):323-32. PubMed ID: 15958054
[TBL] [Abstract][Full Text] [Related]
10. HIF-1α is a crucial factor in the development of peritoneal dissemination via natural metastatic routes in scirrhous gastric cancer.
Miyake S; Kitajima Y; Nakamura J; Kai K; Yanagihara K; Tanaka T; Hiraki M; Miyazaki K; Noshiro H
Int J Oncol; 2013 Nov; 43(5):1431-40. PubMed ID: 23970191
[TBL] [Abstract][Full Text] [Related]
11. Paracrine activation of MET promotes peritoneal carcinomatosis in scirrhous gastric cancer.
Zhao L; Yasumoto K; Kawashima A; Nakagawa T; Takeuchi S; Yamada T; Matsumoto K; Yonekura K; Yoshie O; Yano S
Cancer Sci; 2013 Dec; 104(12):1640-6. PubMed ID: 24118504
[TBL] [Abstract][Full Text] [Related]
12. Preclinical study of a "tailor-made" combination of NK4-expressing gene therapy and gefitinib (ZD1839, Iressa) for disseminated peritoneal scirrhous gastric cancer.
Namiki Y; Namiki T; Yoshida H; Date M; Yashiro M; Matsumoto K; Nakamura T; Yanagihara K; Tada N; Satoi J; Fujise K
Int J Cancer; 2006 Mar; 118(6):1545-55. PubMed ID: 16206271
[TBL] [Abstract][Full Text] [Related]
13. Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes.
Hippo Y; Yashiro M; Ishii M; Taniguchi H; Tsutsumi S; Hirakawa K; Kodama T; Aburatani H
Cancer Res; 2001 Feb; 61(3):889-95. PubMed ID: 11221876
[TBL] [Abstract][Full Text] [Related]
14. The significance of scirrhous gastric cancer cell lines: the molecular characterization using cell lines and mouse models.
Yashiro M; Matsuoka T; Ohira M
Hum Cell; 2018 Oct; 31(4):271-281. PubMed ID: 29876827
[TBL] [Abstract][Full Text] [Related]
15. Establishment and characterization of a new hypoxia-resistant cancer cell line, OCUM-12/Hypo, derived from a scirrhous gastric carcinoma.
Kato Y; Yashiro M; Noda S; Tendo M; Kashiwagi S; Doi Y; Nishii T; Matsuoka J; Fuyuhiro Y; Shinto O; Sawada T; Ohira M; Hirakawa K
Br J Cancer; 2010 Mar; 102(5):898-907. PubMed ID: 20145613
[TBL] [Abstract][Full Text] [Related]
16. A novel transforming growth factor beta receptor kinase inhibitor, A-77, prevents the peritoneal dissemination of scirrhous gastric carcinoma.
Kawajiri H; Yashiro M; Shinto O; Nakamura K; Tendo M; Takemura S; Node M; Hamashima Y; Kajimoto T; Sawada T; Ohira M; Hirakawa K
Clin Cancer Res; 2008 May; 14(9):2850-60. PubMed ID: 18451253
[TBL] [Abstract][Full Text] [Related]
17. N-myc downstream regulated gene 1 (NDRG1) promotes metastasis of human scirrhous gastric cancer cells through epithelial mesenchymal transition.
Ureshino H; Murakami Y; Watari K; Izumi H; Kawahara A; Kage M; Arao T; Nishio K; Yanagihara K; Kinoshita H; Kuwano M; Ono M
PLoS One; 2012; 7(7):e41312. PubMed ID: 22844455
[TBL] [Abstract][Full Text] [Related]
18. Laparoscopic-assisted intraperitoneal chemotherapy for patients with scirrhous gastric cancer.
Ikeguchi M; Matsumoto S; Yoshioka S; Murakami D; Kanaji S; Ohro S; Yamaguchi K; Saito H; Tatebe S; Kondo A; Tsujitani S; Kaibara N
Chemotherapy; 2005 Mar; 51(1):15-20. PubMed ID: 15722628
[TBL] [Abstract][Full Text] [Related]
19. Mesothelial cells differentiate into fibroblast-like cells under the scirrhous gastric cancer microenvironment and promote peritoneal carcinomatosis in vitro and in vivo.
Lv ZD; Wang HB; Dong Q; Kong B; Li JG; Yang ZC; Qu HL; Cao WH; Xu HM
Mol Cell Biochem; 2013 May; 377(1-2):177-85. PubMed ID: 23392771
[TBL] [Abstract][Full Text] [Related]
20. Gene expression changes induced by HIPEC in a murine model of gastric cancer.
Graziosi L; Mencarelli A; Renga B; Santorelli C; Cantarella F; Bugiantella W; Cavazzoni E; Donini A; Fiorucci S
In Vivo; 2012; 26(1):39-45. PubMed ID: 22210714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]